1Life Healthcare Inc. [ONEM] is -1.31% lower this YTD. Is it still time to buy?

1Life Healthcare Inc. [NASDAQ: ONEM] closed the trading session at $17.34 on 09/01/22. The day’s price range saw the stock hit a low of $17.15, while the highest price level was $17.35. The company report on August 3, 2022 that One Medical Announces Results for Second Quarter 2022.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now.


Second Quarter 2022 Ending Total Membership Count of 790,000, a 27% Increase Year-Over-Year. Ending Consumer and Enterprise Membership Count of 750,000 and At-Risk Membership Count of 40,000.

Second Quarter 2022 Net Revenue of $255.8 Million, a 112% Increase Year-Over-Year.

The stocks have a year to date performance of -1.31 percent and weekly performance of -1.03 percent. The stock has been moved at 64.36 percent over the last six months. The stock has performed 1.40 percent around the most recent 30 days and changed 95.93 percent over the most recent 3-months.

If compared to the average trading volume of 5.33M shares, ONEM reached to a volume of 3419799 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about 1Life Healthcare Inc. [ONEM]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ONEM shares is $17.75 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ONEM stock is a recommendation set at 2.70. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Deutsche Bank have made an estimate for 1Life Healthcare Inc. shares, keeping their opinion on the stock as Hold, with their previous recommendation back on July 12, 2022. While these analysts kept the previous recommendation, Evercore ISI raised their target price from $11 to $12. The new note on the price target was released on July 11, 2022, representing the official price target for 1Life Healthcare Inc. stock. Previously, the target price had yet another raise to $15, while BTIG Research analysts kept a Buy rating on ONEM stock.

The Average True Range (ATR) for 1Life Healthcare Inc. is set at 0.17, with the Price to Sales ratio for ONEM stock in the period of the last 12 months amounting to 3.84. The Price to Book ratio for the last quarter was 2.08, with the Price to Cash per share for the same quarter was set at 1.76.

ONEM stock trade performance evaluation

1Life Healthcare Inc. [ONEM] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.03. With this latest performance, ONEM shares gained by 1.40% in over the last four-week period, additionally plugging by 64.36% over the last 6 months – not to mention a drop of -29.11% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ONEM stock in for the last two-week period is set at 69.79, with the RSI for the last a single of trading hit 64.58, and the three-weeks RSI is set at 69.75 for 1Life Healthcare Inc. [ONEM]. The present Moving Average for the last 50 days of trading for this stock 14.28, while it was recorded at 17.31 for the last single week of trading, and 12.23 for the last 200 days.

1Life Healthcare Inc. [ONEM]: An insightful look at the core fundamentals

Operating Margin for any stock indicates how profitable investing would be, and 1Life Healthcare Inc. [ONEM] shares currently have an operating margin of -39.46 and a Gross Margin at +22.50. 1Life Healthcare Inc.’s Net Margin is presently recorded at -40.97.

Return on Equity for this stock declined to -22.37, with Return on Assets sitting at -13.16.

1Life Healthcare Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.60 and a Current Ratio set at 2.60.

1Life Healthcare Inc. [ONEM]: Insider Ownership positions

There are presently around $2,831 million, or 87.10% of ONEM stock, in the hands of institutional investors. The top three institutional holders of ONEM stocks are: TIGER GLOBAL MANAGEMENT LLC with ownership of 16,986,234, which is approximately -3.887% of the company’s market cap and around 0.10% of the total institutional ownership; VANGUARD GROUP INC, holding 16,154,077 shares of the stock with an approximate value of $280.11 million in ONEM stocks shares; and BLACKROCK INC., currently with $257.44 million in ONEM stock with ownership of nearly 33.456% of the company’s market capitalization.

Positions in 1Life Healthcare Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 93 institutional holders increased their position in 1Life Healthcare Inc. [NASDAQ:ONEM] by around 18,853,639 shares. Additionally, 86 investors decreased positions by around 7,454,141 shares, while 39 investors held positions by with 136,959,707 shares. The mentioned changes placed institutional holdings at 163,267,487 shares, according to the latest SEC report filing. ONEM stock had 29 new institutional investments in for a total of 2,269,446 shares, while 29 institutional investors sold positions of 1,809,517 shares during the same period.


Please enter your comment!
Please enter your name here